MeSH term
Frequency | Condition_Probility | Animals | 10 | 0.0 |
Cells, Cultured | 13 | 0.0 |
Humans | 23 | 0.0 |
Male | 3 | 0.0 |
Mice | 8 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Transforming Growth Factor beta/pharmacology | 3 | 0.0 |
Glucuronosyltransferase/*metabolism | 2 | 3.0 |
*Glycosyltransferases | 15 | 40.0 |
Immunoenzyme Techniques | 2 | 0.0 |
*Membrane Proteins | 15 | 1.0 |
Middle Aged | 2 | 0.0 |
*Transferases | 15 | 40.0 |
*Xenopus Proteins | 15 | 4.0 |
Amino Acid Sequence | 4 | 0.0 |
Base Sequence | 7 | 0.0 |
Cattle | 3 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Hyaluronic Acid/biosynthesis | 2 | 20.0 |
Molecular Sequence Data | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 17 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Transfection | 3 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Interleukin-1/*pharmacology | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Glucuronosyltransferase/*genetics | 8 | 7.0 |
Dexamethasone/pharmacology | 2 | 0.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Hydrocortisone/pharmacology | 2 | 2.0 |
Platelet-Derived Growth Factor/pharmacology | 2 | 1.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Glucuronosyltransferase/genetics/*metabolism | 2 | 5.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Transforming Growth Factor beta/*pharmacology | 3 | 0.0 |
COS Cells | 2 | 0.0 |
DNA, Complementary/chemistry | 2 | 1.0 |
Glucuronosyltransferase/chemistry/*genetics | 2 | 33.0 |
Sequence Alignment | 2 | 0.0 |
Xenopus laevis | 2 | 0.0 |
Fibroblasts/enzymology | 2 | 1.0 |
Gene Expression Regulation, Enzymologic/*drug effects | 2 | 1.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
